Cargando…

Safety and Pharmacokinetics of HTL0018318, a Novel M(1) Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects

INTRODUCTION: HTL0018318 is a selective muscarinic M(1) receptor partial agonist under development for the symptomatic treatment of dementias, including Alzheimer’s disease. Clinically, HTL0018318 would likely be used alone or in conjunction with cholinesterase inhibitors (e.g. donepezil). OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bakker, Charlotte, van der Aart, Jasper, Labots, Geert, Liptrot, Jan, Cross, David M., Klaassen, Erica S., Dickinson, Steve, Tasker, Tim, Groeneveld, Geert Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363684/ https://www.ncbi.nlm.nih.gov/pubmed/34164794 http://dx.doi.org/10.1007/s40268-021-00352-5

Ejemplares similares

First‐in‐man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M(1)‐receptor partial agonist for the treatment of dementias
por: Bakker, Charlotte, et al.
Publicado: (2021)

Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M(1) receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose study
por: Bakker, Charlotte, et al.
Publicado: (2021)

Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M(1)‐acetylcholine receptor agonist: A randomized cross‐over trial
por: Bakker, Charlotte, et al.
Publicado: (2021)

A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M(1) receptor agonist HTL0018318 in patients with mild‐to‐moderate Alzheimer's disease
por: Nathan, Pradeep J., et al.
Publicado: (2022)

Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil
por: Tariot, Pierre N., et al.
Publicado: (2022)

Safety, pharmacokinetics, and pharmacodynamics of Gln‐1062, a prodrug of galantamine
por: Bakker, Charlotte, et al.
Publicado: (2020)

No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge model
por: Baakman, Anne Catrien, et al.
Publicado: (2019)

Finite Temperature Meson Correlation Functions in HTL Approximation
por: Karsch, Frithjof, et al.
Publicado: (2000)

Towards a better understanding of the HTL process of lignin-rich feedstock
por: Ciuffi, Benedetta, et al.
Publicado: (2021)

Structural basis for specific inhibition of the highly sensitive ShHTL7 receptor
por: Shahul Hameed, Umar, et al.
Publicado: (2018)

Drosophila FGFR/Htl signaling shapes embryonic glia to phagocytose apoptotic neurons
por: Ayoub, Malak, et al.
Publicado: (2023)

Stabilizing high-humidity perovskite solar cells with MoS(2) hybrid HTL
por: Fahsyar, Puteri Nor Aznie, et al.
Publicado: (2023)

A crossover study evaluating the sex‐dependent and sensitizing effects of sleep deprivation using a nociceptive test battery in healthy subjects
por: Hijma, Hemme, et al.
Publicado: (2022)

Structural analysis of HTL and D14 proteins reveals the basis for ligand selectivity in Striga
por: Xu, Yuqun, et al.
Publicado: (2018)

Recovery of Terephthalic Acid from Densified Post-consumer Plastic Mix by HTL Process
por: Agostini, Ilaria, et al.
Publicado: (2022)

First in human study with a prodrug of galantamine: Improved benefit-risk ratio?
por: Baakman, Anne C., et al.
Publicado: (2016)

The ultraviolet B inflammation model: Postinflammatory hyperpigmentation and validation of a reduced UVB exposure paradigm for inducing hyperalgesia in healthy subjects
por: Siebenga, Pieter S., et al.
Publicado: (2019)

Parasitic pharmacology: A plausible mechanism of action for cannabidiol
por: Groeneveld, Geert Jan, et al.
Publicado: (2019)

First‐in‐human trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of zagociguat (CY6463), a CNS‐penetrant soluble guanylyl cyclase stimulator
por: van Kraaij, Sebastiaan J. W., et al.
Publicado: (2023)

Symptomatic Treatment of Vascular Cognitive Impairment (STREAM-VCI): Protocol for a Cross-Over Trial
por: Leijenaar, Jolien Fleur, et al.
Publicado: (2018)

Heterotic Trait Locus (HTL) Mapping Identifies Intra-Locus Interactions That Underlie Reproductive Hybrid Vigor in Sorghum bicolor
por: Ben-Israel, Imri, et al.
Publicado: (2012)

Gene Polymorphisms Affecting the Pharmacokinetics and Pharmacodynamics of Donepezil Efficacy
por: Lu, Jin, et al.
Publicado: (2020)

Potentials of incretin‐based therapies in dementia and stroke in type 2 diabetes mellitus
por: Groeneveld, Onno N, et al.
Publicado: (2015)

Profiling donepezil template into multipotent hybrids with antioxidant properties
por: Mezeiova, Eva, et al.
Publicado: (2018)

Effect of Donepezil on Group II mGlu Receptor Agonist- or Antagonist-Induced Amnesia on Passive Avoidance in Mice
por: Sato, Tomoaki, et al.
Publicado: (2003)

Effect of Water Extract of Mangosteen Pericarp on Donepezil Pharmacokinetics in Mice
por: Bae, Mingoo, et al.
Publicado: (2021)

Donepezil Beyond Alzheimer's Disease? A Narrative Review of Therapeutic Potentials of Donepezil in Different Diseases
por: Pooladgar, Parham, et al.
Publicado: (2022)

A phase I, randomized, double‐blind, placebo‐controlled, single‐ and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX‐128, a highly selective Na(v)1.8 inhibitor, in healthy adults
por: Hijma, Hemme J., et al.
Publicado: (2021)

A Novel Multiepitope Vaccine Against Bladder Cancer Based on CTL and HTL Epitopes for Induction of Strong Immune Using Immunoinformatics Approaches
por: Jahangirian, Ehsan, et al.
Publicado: (2022)

Population Pharmacokinetic/Pharmacodynamic Analysis of Nociceptive Pain Models Following an Oral Pregabalin Dose Administration to Healthy Subjects
por: van Esdonk, Michiel J., et al.
Publicado: (2018)

First‐in‐human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR‐324, a dual enkephalinase inhibitor for pain management
por: Moss, Laurence M., et al.
Publicado: (2021)

Study of a Lead-Free Perovskite Solar Cell Using CZTS as HTL to Achieve a 20% PCE by SCAPS-1D Simulation
por: Piñón Reyes, Ana C., et al.
Publicado: (2021)

A cross-sectional study in healthy elderly subjects aimed at development of an algorithm to increase identification of Alzheimer pathology for the purpose of clinical trial participation
por: Prins, Samantha, et al.
Publicado: (2021)

Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteers
por: Kim, Yo Han, et al.
Publicado: (2015)

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
por: Hay, Justin L., et al.
Publicado: (2016)

Transdermal donepezil on the treatment of Alzheimer’s disease
por: Sozio, Piera, et al.
Publicado: (2012)

Pharmacogenetics of Donepezil and Memantine in Healthy Subjects
por: Ovejero-Benito, María C., et al.
Publicado: (2022)

Durable recovery from amblyopia with donepezil
por: Wu, Carolyn, et al.
Publicado: (2023)

Gender differences in clinical registration trials: is there a real problem?
por: Labots, Geert, et al.
Publicado: (2018)

Exploring hydrothermal liquefaction (HTL) of digested sewage sludge (DSS) at 5.3 L and 0.025 L bench scale using experimental design
por: Hegdahl, Stian Hersvik, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j556bcim33kfo7bo8p2q489mbt